L

Lundbeckfonden / Lundbeck Foundation

59 employees

Lundbeckfonden Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by Lundbeck Foundation

Investor insights

Sectors invested in

Biotechnology41
Health Care27
Therapeutics21
Biopharma12
Medical11
Life Science11
Pharmaceutical10
Medical Device6
Inflammatory Bowel Diseases5
Metagenomics5
Immunotherapies5
Auto-immunity5
Immuno-oncology5
Microbiome5
Manufacturing4
Clinical Trials4
Immuno-oncology and Re-programming the Tumor Microenvironment2
Colposcope2
Spectral Imaging2
Women's Health2

Funding rounds participated in

$31M sweet spot round size

Most of their 56 investments are in rounds between $15M and $43M

Investor type

Venture Capital

Basic info

Industry

financial services

Sectors

Biotechnology
Venture Capital

Date founded

1954

Investments made

N

Notify Therapeutics raised $5.3M on September 25, 2023

Investors: Lundbeckfonden / Lundbeck Foundation

W

Women in Life Science Denmark raised $69K on June 13, 2023

Investors: Lundbeckfonden / Lundbeck Foundation

U

Undisclosed raised $37M on May 25, 2023

Investors: Libertatis Ergo Holding B.V., Ysios Capital, Wake Forest Innovation Quarter, Sound Bioventures, BGV (BioGeneration Ventures) and Lundbeckfonden / Lundbeck Foundation

L

LEXEO Therapeutics raised $100M on September 9, 2021

Investors: Laurion Capital Management LP, Gray's Creek Capital Partners, Omega Funds, Longitude Capital, Intus Capital, Woodline Partners LP, PBM Capital Group and Lundbeckfonden / Lundbeck Foundation

A

Aura Biosciences raised $80M on March 22, 2021

Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., Chiesi Ventures, Arix Bioscience plc, Advent Life Sciences, Ysios Capital, Surveyor Capital, Medicxi and Lundbeckfonden / Lundbeck Foundation

L

LEXEO Therapeutics raised $85M on January 7, 2021

Investors: Omega Funds, Woodline Partners LP, The Invus Group, PBM Capital Group, Longitude Capital and Lundbeckfonden / Lundbeck Foundation

R

Reneo Pharmaceuticals raised $95M on December 9, 2020

Investors: Aisling Capital, RiverVest Venture Partners, Chiesi Ventures, Pappas Capital, Abingworth and Lundbeckfonden / Lundbeck Foundation

U

Undisclosed raised $36M on July 8, 2020

Investors: Ysios Capital, EQT Life Sciences, BGV (BioGeneration Ventures), Inkef, InnovationQuarter and Lundbeckfonden / Lundbeck Foundation

A

Amplyx Pharmaceuticals, Inc raised $53M on May 19, 2020

Investors: RiverVest Venture Partners, Adage Capital Management, Pappas Capital, Sofinnova Ventures, Russia technology fund, Arix Bioscience plc and Lundbeckfonden / Lundbeck Foundation

I

IO Biotech raised $8.7M on May 12, 2020

Investors: Sunstone Life Science Ventures, Novo Holdings and Lundbeckfonden / Lundbeck Foundation

FAQ